Griffin Hospital
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Griffin Hospital sits in the top decile of US sponsors by registered trial count (#696 of 15,742 sponsors by registered trial count).
Griffin Hospital: 22 sponsored US clinical trials, none currently recruiting.
Griffin Hospital sponsors 22 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 20 completed. 1 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 2 trials.
Top-decile sponsor footprint
Griffin Hospital ranks in the top decile of sponsors by registered trial count (#696 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
20 of 21 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
22 total, page 1 of 1
Oral FMT (Fecal Microbial Transplant) in Subjects with Multiple Sclerosis
NCT04096443
Effects of Fos Biomedical Device on Diabetes Risk Factors and Sleep Quality in Adults at Risk for Type 2 Diabetes
NCT05628597
COVID-19 Booster Vaccination in Persons With Multiple Sclerosis
NCT05081271
The Impact of Consumption of Eggs in the Context of Plant-Based Diets on Endothelial Function, Diet Quality, and Cardio-Metabolic Risk Factors in Adults at Risk for Type 2 Diabetes
NCT04316429
Post-prandial Effects of Extra Virgin Olive Oil on Endothelial Function in Adults at Risk for Type 2 Diabetes
NCT04025281
Mindfulness Meditation in Treating Insomnia in Multiple Sclerosis
NCT03949296
Teriflunomide Male Transmission Study
NCT02679885
Effects of ISOThrive on Bodyweight, Body Composition, Hunger/Satiety and Cardiac Risk Measures in Overweight Adults
NCT02501356
Egg Ingestion in Adults With Type 2 Diabetes
NCT02052037
Effects of Cocoa on Ambulatory Blood Pressure and Vascular Function in Patients With Stage I Hypertension
NCT01672840
Snacking, Satiety &Weight: A Randomized, Controlled Trial
NCT02050165
Walnut Ingestion in Adults at Risk for Diabetes: Effects on Body Composition, Diet Quality, and Cardiac Risk Measures
NCT02330848
Effects of Egg Ingestion on Endothelial Function in Adults With Coronary Artery Disease
NCT01672567
Effects of Walnuts on Endothelial Function in Overweight Adults With at Least One Factor of Metabolic Syndrome
NCT01413646
Effects of Juice Plus+® Supplementation on Endothelial Function in Overweight Men
NCT01533987
Automated Guidance Tool for Medical Encounters Addressing Therapeutic Lifestyle Changes (AuGMEnT).
NCT00790491
Effects of Walnut Consumption on Endothelial Function in Type 2 Diabetes
NCT00901043
Health Literacy in Patients With Congestive Heart Failure
NCT00508716
Cocoa and Endothelial Function in Adults With Elevated BMI
NCT00538083
Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes
NCT00067626
Effect of Fruit and Vegetable Concentrates on Endothelial Function in Persons With Metabolic Syndrome
NCT01224743
Trial of Safety Nets In Hospitalized Patients
NCT00409370
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 1 |
| Phase 3 | 1 |
Therapeutic Areas
How the Griffin Hospital early-phase archive is shaped
22 indexed studies, none listed as recruiting (0% open); 20 completed (91%).
Phase mix: 1 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (2 trials), 6 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Griffin Hospital: archived-pipeline peers nationwide
Peers matched on 22 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Griffin Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 22 archived trials
- Alaunos Therapeutics · 22 trials · 0% recruiting
- Alexza Pharmaceuticals · 22 trials · 0% recruiting
- Calithera Biosciences · 22 trials · 0% recruiting
- Fate Therapeutics · 22 trials · 14% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Griffin Hospital page
22 registered trials is a research-attention snapshot, not an endorsement of Griffin Hospital or any single study.
- None of Griffin Hospital's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Type 2 Diabetes is the condition Griffin Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Griffin Hospital pipeline card: 22 registered trials from official public datasets.Report a data error.